PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
NCT06422871
This study is recruiting at 7 US sites in 6 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this observational study is to increase the understanding of the safety and performance of Merit Medical's HeRO Graft System (HeRO) and Super HeRO Adaptor and Support Seal System (Super HeRO) devices. This study includes adults that are being treated with one of these devices as part of their regular medical care for maintaining long-term dialysis access when all other dialysis access options have failed.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- End Stage Renal Disease
- Hemodialysis Access Failure
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Merit Medical Systems, Inc.
- Last updated on ClinicalTrials.gov
- June 1, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
District of Columbia · 1
- MedStar Washington Hospital Center · Washington D.C., DC
Florida · 1
- Sarasota Memorial Health Care System · Sarasota, FL
North Carolina · 1
- WakeMed · Raleigh, NC
Pennsylvania · 1
- University Pittsburgh Medical Center · Pittsburgh, PA
Texas · 2
- Baylor Scott & White Heart and Vascular Hospital - Dallas · Dallas, TX
- Houston Methodist Hospital · Houston, TX
Virginia · 1
- Sentara Norfolk General Hospital · Norfolk, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.